Cargando…
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1
Glucocorticoids such as dexamethasone are widely co-prescribed with cytotoxic therapy because of their proapoptotic effects in lymphoid cancer, reduction of inflammation and edema and additional benefits. Concerns about glucocorticoid-induced therapy resistance, enhanced metastasis and reduced survi...
Autores principales: | Liu, Li, Aleksandrowicz, Ewa, Schönsiegel, Frank, Gröner, Daniel, Bauer, Nathalie, Nwaeburu, Clifford C, Zhao, Zhefu, Gladkich, Jury, Hoppe-Tichy, Torsten, Yefenof, Eitan, Hackert, Thilo, Strobel, Oliver, Herr, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680577/ https://www.ncbi.nlm.nih.gov/pubmed/28981109 http://dx.doi.org/10.1038/cddis.2017.455 |
Ejemplares similares
-
Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2018) -
Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer
por: Abukiwan, Alia, et al.
Publicado: (2023) -
Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness
por: Zhao, Zhefu, et al.
Publicado: (2017) -
Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl
por: Nwaeburu, Clifford C., et al.
Publicado: (2016) -
Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells
por: LABSCH, SABRINA, et al.
Publicado: (2014)